4 March 2021
Ocugen and Bharat Biotech announced the former’s whole inactivated Covid-19 vaccine COVAXIN achieved 81% efficacy in its first interim analysis of the Phase II study. Analysis from the National Institute of Virology (NIV) indicate that the vaccine’s has the ability to protection against the UK and other variants.
Health Canada has approved a submission from Pfizer and BioNTech to allow their Covid-19 vaccine to be transported and stored at standard freezer temperatures, between -25°C and -15°C, instead of ultra-cold conditions for two weeks. This facilitates more flexible transportation, as well as local re-distribution of the vaccine.
The Russian Direct Investment Fund (RDIF)’s Sputnik V Covid-19 has been approved by regulatory agencies in the Republic of Angola, the Congo and Djibouti. Sputnik V is now emergency approved in 42 countries worldwide.